Shardul Amarchand Mangaldas & Co. (SAM) advised AION Investments Private Limited (“AION”), a special purpose vehicle of a fund managed by affiliates of Apollo Global Management, Inc., on the sale of its entire stake held in Planetcast Media Services Limited (“Planetcast”) to Arugn Technologies Private Limited.   The transaction involved AION’s complete exit from Planetcast… Read More +

Shardul Amarchand Mangaldas & Co. (SAM) is proud to announce that its Executive Chairman, Dr. Shardul S. Shroff, has been conferred the prestigious ACES 2025 Lifetime Achievement Award, a recognition reserved for leaders whose integrity, governance standards, and long-standing influence have shaped Asia’s corporate landscape. The ACES (Asia Corporate Excellence & Sustainability) Awards are among… Read More +

Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Eris Lifesciences Limited (“ELL”) in connection with its proposed acquisition of 30% of the total share capital of Swiss Parenterals Limited (“SPL”) (in which ELL currently holds 70% of the share capital) from Mr. Naishadh Shah (Director, SPL), for an aggregate consideration of… Read More +

Shardul Amarchand Mangaldas & Co. (SAM) advised long-standing client, British American Tobacco p.l.c. (BAT), on the strategic divestment of part of its shareholding in ITC Hotels Limited (ITC Hotels) through a secondary transfer executed via an accelerated bookbuild process for an aggregate consideration of approximately USD 429 million.   This deal involves the offloading of… Read More +